Zymeworks (ZYME) Capital Expenditures Growth (1y) (2022 - 2026)
Zymeworks (ZYME) Capital Expenditures Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 143.40% |
| 10 | Zymeworks | 1.72 Bn | 1.36 Bn | - | 525.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 525.00% |
| Dec 31, 2025 | 85.03% |
| Sep 30, 2025 | -54.39% |
| Jun 30, 2025 | -33.93% |
| Dec 31, 2024 | 115.73% |
| Sep 30, 2024 | -3.33% |
| Jun 30, 2024 | -2.99% |
| Dec 31, 2023 | -321.10% |
| Sep 30, 2023 | 117.25% |
| Jun 30, 2023 | -69.88% |
| Mar 31, 2023 | -90.72% |
| Dec 31, 2022 | -266.90% |